|
Match
|
Document |
Document Title |
|
|
6849269 |
Proliposomal drug delivery system
This invention relates to proliposomal drug-delivery systems for medicaments. In particular, it relates to enteric-coated proliposomal formulations for poorly water soluble drugs and methods for...
|
|
|
6849120 |
Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and methods of preparing the crystalline forms
The present invention provides an improved process for preparing modafinil, whereby it may be isolated in high purity by a single crystallization. The process produces modafinil free of sulphone...
|
|
|
6846495 |
Compositions having improved delivery of actives
The present invention pertains to compositions having improved delivery of pharmaceutical actives. These compositions comprise pharmaceutical actives in an anhydrous solvent. These compositions may...
|
|
|
6844020 |
Solutions of carotenoids for use in foods and personal care products
Concentrated solutions of carotenoids in essential oils and cosmetic oils for use in foods, beverages, and personal care products. The concentrated solutions comprise between about 0.8 weight % and...
|
|
|
6844048 |
Substrates for powder deposition containing conductive domains
Provided is, among other things, a conductive inlay film comprising: a layer of dielectric film having a pattern of holes suitable to define selected regions to which particles will be deposited by...
|
|
|
6841167 |
β-carboline pharmaceutical compositions
A soft capsule containing a solution or suspension of a PDE5 inhibitor, and use of the capsule in treating sexual dysfunction.
|
|
|
6841169 |
Stabilizer for pharmacons
The present invention relates to an auxiliary substance for an active substance, such as a pharmacon. The auxiliary substance has a stabilizing action. The auxiliary substance further has a...
|
|
|
6838091 |
Formulations comprising lipid-regulating agents
The present invention is directed to a formulation comprising a lipid-regulating agent dissolved in at least one monoglyceride as the primary solvent medium for said agent. One or more emulsifiers...
|
|
|
6833340 |
System for delivery of active substances
A method of delivery of active substances to a water-filled environment, specifically a toilet bowl, with a water-soluble polymer as the primary delivery means. The present invention is activated...
|
|
|
6833362 |
Method and composition for the accelerated in vivo removal of ethanol
A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or...
|
|
|
6830760 |
Glyburide composition
The present invention relates to a physical form of the known drug substance glyburide, also known as glibenclamide, and chemically defined as...
|
|
|
6827945 |
Nutritional supplements and methods of using same
A nutritional supplement for providing, and for promoting the health of salivary glands and/or supporting normal or healthy swallowing includes ingredients obtainable from turmeric, ginger, and...
|
|
|
6828334 |
Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition
The present invention relates to pharmaceutical compositions containing fenofibrate in the form of an inclusion complex with cyclodextrin, having high dissolution profile and in vivo enhanced...
|
|
|
6822000 |
Bioerodible poly (orthoesters) from dioxolane-based diketene acetals
Bioerodible poly(orthoesters) useful as orthopedic implants or vehicles for the sustained delivery of pharmaceutical, cosmetic and agricultural agents contain hydrogen bonding groups and α-hydroxy...
|
|
|
6814972 |
Composition for prevention and/or treatment of vascular diseases, comprising propionyl L-carnitine and coenzyme Q10
A composition is disclosed which is suitable for the prevention and/or treatment of vasculopathic, cardiac, central and peripheral cerebral disturbances and for the prevention of learning disorders...
|
|
|
6811795 |
Anti-cancer extracts and pharmaceutical compositions and methods
Compositions having therapeutic value derived from plant material from one or more of Glinus lotoides, Ruta chalepensis, Hagenia abyssinica , and/or Millettia ferruginea are provided. The...
|
|
|
6805857 |
Method of modulating factor D, factor H and CD4 cell immune response with a polystyrene sulfonate, alginate, and saline infusion solution
Anthrax bio-terrorism is a poor man's nuclear bomb with devastating effects on the freedom and economy of any nation. No nation is immune. Urgently, there is a need for life saving technology that...
|
|
|
RE38629 |
Solid oral dosage form comprising a combination of metformin and glibenclamide
The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability...
|
|
|
RE38628 |
Pharmaceutical compositions
A method of treatment of a condition selected from the group comprising conjunctivitis, keratitis, ‘allergic eyes’, adenovirus infections, corneal homograft rejection, anterior uveitis, nasal...
|
|
|
6805881 |
Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
The present invention relates to orally administrable multiple-unit sustained-release dose forms having controlled agitation-independent release of active compound and processes for their...
|
|
|
6797282 |
Combination progestin oral contraceptive regimen
An oral contraception regimen which comprises sequentially administering two or more progestational agents exhibiting different effects on the human endometrium in combination with an estrogen. The...
|
|
|
6793934 |
Solid oral dosage form
A pharmaceutical composition comprising a solid carrier containing a liquid selected from the group consisting of a liquid active agent, a liquid enhancer, or a combination thereof.
|
|
|
6790495 |
Method for manufacturing a shape body containing a starch, a homogenised mass containing starch and a device for manufacturing a soft capsule
The invention relates to a method for manufacturing a starch-containing shape body and a homogenised, starch-containing mass and shape bodies manufactured therefrom. The method is carried out in a...
|
|
|
6787155 |
Anti-inflammatory pharmaceutical formulations
An oral pharmaceutical dosage form including a mixture of a delay release formulation of a non-steroidal anti-inflammatory drug (NSAID) and a mixture containing a prostaqlandin and one or more...
|
|
|
6783770 |
Hard capsules comprising polymers of vinyl esters and polyethers, their use and production
The present invention relates to hard capsules comprising (A) polymers obtainable by free-radical polymerization of a) at least one vinyl ester in the presence of b) polyether-containing compounds...
|
|
|
6783773 |
Composition comprising amoxicillin and potassium clavulanate
Bacterial infections may be treated using a high dosage regimen of amoxicillin and potassium clavulanate. Preferably, the dosage is provided by a bilayer tablet.
|
|
|
6783774 |
Substance that stop any kind of bleeding within one second for medical, surgical, postsurgical and dental uses
There is disclosed a method for stopping bleeding and forming black blood coagulation on contact, comprising administering powdered L-threo-hex-2-enono-1,4-lactone thereof to a bleeding site in an...
|
|
|
6780440 |
Herbal compositions and methods for diabetes and weight loss management
Herbal compositions and methods suitable for weight loss management and for treating diabetes are disclosed. The compositions comprise Ferula hermonis or an extract thereof, or Ferula hermonis ...
|
|
|
6776985 |
Encapsulated cells producing viral particles
The present invention relates to encapsulated cells producing viral particles, especially retroviral particles containing the genome of a retroviral vector carrying therapeutic genes, to methods...
|
|
|
6776999 |
Expandable gastroretentive therapeutical system with prolonged stomach retention time
The invention relates to a device for delaying the pylorus passage of orally administered medicament forms. Said device comprises a component which expands upon contact with the gastric juice and a...
|
|
|
6773720 |
Mesalazine controlled release oral pharmaceutical compositions
Controlled-release oral pharmaceutical compositions containing as active ingredient 5-amino-salicylic acid, comprising: a) an inner lipophilic matrix consisting of substances with a melting point...
|
|
|
6770296 |
Process for producing coated preparation and its use
There is provide a novel process for producing a coated preparation composed of a hydrophilic core material coated with a coat material selected from hydrophobic hot-melt lipid to control...
|
|
|
6770300 |
Rapidly decomposing chitosan-based pellets
The invention relates to porous, rapidly disintegrating, active substance-containing pellets based on chitosan or a basic chitosan derivative, manufactured according to a dripping method wherein an...
|
|
|
6770293 |
Soft capsules comprising polymers of vinyl esters and polyethers, the use and production thereof
The present invention relates to soft capsules comprising (a) polymers prepared by polymerization of vinyl esters in the presence of polyethers (b) where appropriate structure-improving...
|
|
|
6767555 |
Pharmaceutical compositions
This invention provides composition comprising a cyclosporin and a carrier medium.
|
|
|
6767556 |
Pharmaceutical compositions comprising moexipril magnesium
Stable solid compositions comprising moxeipril magnesium can be made using moexipril or an acid addition salt thereof, by reacting the moxeipril or acid addition salt with an alkaline magnesium...
|
|
|
6767563 |
Immune functions
An inventive and proprietary food supplement formula per unit to enhance the body's natural immune function against viral and infectious diseases and cancer. The food supplement per unit in liquid...
|
|
|
6767567 |
Ingestible elements
The invention relates mainly to an element suitable for being ingested, the element including at least one air-passing channel making it possible to avoid choking in the event of being swallowed...
|
|
|
6762267 |
Controlled release polyacrylic acid granules and a process for preparing the same
The present invention pertains to a method for forming polyacrylic acid granules and granules formed therefrom wherein the granules are flowable, have an increased bulk density relative to the as...
|
|
|
6761903 |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present...
|
|
|
6761905 |
Process for the preparation of direct tabletting formulations and aids
A thermal adhesion granulation process for preparing direct tabletting formulations or aids is disclosed. The process comprises the step of subjecting all or part of a mixture comprising: A) from...
|
|
|
6761898 |
Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders
The present invention relates to a composition, which contains L-carnitine or alkanoyl-L-carnitine, and a glucosaminoglycan or a constituent thereof, suitable for the prevention of articular...
|
|
|
6753333 |
Chiral fluoroquinolone arginine salt forms
The invention relates to the new arginine salt forms of S-(−)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-m
ethyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid, a process for their...
|
|
|
6752997 |
Process for preparing non-hygroscopic sodium valproate composition
The invention is directed to non-hygroscopic oral pharmaceutical compositions of a salt of valproic acid, and processes for preparing the compositions. The non-hygroscopic pharmaceutical...
|
|
|
6753006 |
Paclitaxel-containing formulations
In accordance with the present invention, there are provided compositions and methods useful for the in vivo delivery of a pharmaceutically active agent, wherein the agent is associated with a...
|
|
|
6753010 |
Soft gelatin capsule containing angelica oil
The present invention relates to a soft gelation capsule containing angelica essential oil which consists of capsule material and medicinal oil. Wherein the medicinal oil consists of angelica...
|
|
|
6753338 |
Methods for treating hypertension, angina, and congestive heart failure using of optically pure (-) amlodipine
Methods and compositions are disclosed utilizing the optically pure (−) isomer of amlodipine. This compound is a potent drug for the treatment of hypertension while avoiding the concomitant...
|
|
|
6750249 |
Controlled release oral preparations of esculetin and its derivatives
The present invention relates to an oral preparation of esculetin with controlled release. The oral preparation of esculetin with controlled release of the present invention comprises a gel-forming...
|
|
|
6749867 |
Delivery system for omeprazole and its salts
The present invention provides a time-release dosage form for delivering an acid-labile pharmaceutical, such as omeprazole, into the upper portion of the gastrointestinal tract downstream of the...
|
|
|
6750209 |
Advanced glycation end-product intermediaries and post-amadori inhibition
The instant invention provides compositions and methods for modeling post-Amadori AGE formation and the identification and characterization of effective inhibitors of post-Amadori AGE formation,...
|